| Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ... Annals of internal medicine 163 (1), 40-51, 2015 | 545 | 2015 |
| Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis EP Navarese, JG Robinson, M Kowalewski, M Kołodziejczak, F Andreotti, ... Jama 319 (15), 1566-1579, 2018 | 474 | 2018 |
| Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus EP Navarese, A Buffon, F Andreotti, M Kozinski, N Welton, T Fabiszak, ... The American journal of cardiology 111 (8), 1123-1130, 2013 | 388 | 2013 |
| Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial J Kubica, P Adamski, M Ostrowska, J Sikora, JM Kubica, WD Sroka, ... European heart journal 37 (3), 245-252, 2016 | 320 | 2016 |
| Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice … EP Navarese, K Tandjung, B Claessen, F Andreotti, M Kowalewski, ... Bmj 347, 2013 | 258 | 2013 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| Optimal timing of coronary invasive strategy in non–ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis EP Navarese, PA Gurbel, F Andreotti, U Tantry, YH Jeong, M Kozinski, ... Annals of internal medicine 158 (4), 261-270, 2013 | 200 | 2013 |
| Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study G Montalescot, B Pitt, E Lopez de Sa, CW Hamm, M Flather, F Verheugt, ... European heart journal 35 (34), 2295-2302, 2014 | 195 | 2014 |
| Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ... Journal of the American Heart Association 5 (3), e002197, 2016 | 154 | 2016 |
| Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention EP Navarese, M Kowalewski, F Andreotti, M van Wely, C Camaro, ... The American journal of cardiology 113 (10), 1753-1764, 2014 | 136 | 2014 |
| Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI study JM SILLER‐MATULA, G Delle‐Karth, IM Lang, T Neunteufl, M Kozinski, ... Journal of Thrombosis and Haemostasis 10 (4), 529-542, 2012 | 125 | 2012 |
| First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials … EP Navarese, M Kowalewski, D Kandzari, A Lansky, B Górny, Ł Kołtowski, ... Open heart 1 (1), e000064, 2014 | 124 | 2014 |
| Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials EP Navarese, SU Khan, M Kołodziejczak, J Kubica, S Buccheri, ... Circulation 142 (2), 150-160, 2020 | 123 | 2020 |
| Low‐molecular‐weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST‐elevation myocardial infarction: a meta‐analysis EP Navarese, G De Luca, F Castriota, M Kozinski, PA Gurbel, CM Gibson, ... Journal of Thrombosis and Haemostasis 9 (10), 1902-1915, 2011 | 117 | 2011 |
| Critical appraisal of inflammatory markers in cardiovascular risk stratification M Krintus, M Kozinski, J Kubica, G Sypniewska Critical reviews in clinical laboratory sciences 51 (5), 263-279, 2014 | 116 | 2014 |
| Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials EP Navarese, J Kubica, F Castriota, CM Gibson, G De Luca, A Buffon, ... EuroIntervention 7 (8), 985-994, 2011 | 108 | 2011 |
| Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis JM Siller-Matula, K Huber, G Christ, K Schrör, J Kubica, H Herkner, ... Heart 97 (2), 98-105, 2011 | 106 | 2011 |
| Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis EP Navarese, AJ Lansky, DJ Kereiakes, J Kubica, PA Gurbel, DA Gorog, ... European heart journal 42 (45), 4638-4651, 2021 | 102 | 2021 |
| Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors J Kubica, A Kubica, B Jilma, P Adamski, EL Hobl, EP Navarese, ... International Journal of Cardiology 215, 201-208, 2016 | 93 | 2016 |
| Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome EP Navarese, V Schulze, F Andreotti, M Kowalewski, M Kołodziejczak, ... JACC: Cardiovascular Interventions 8 (1 Part B), 201-213, 2015 | 90 | 2015 |
Aldona Kubica, PhD, FAHA Orcid.org/...Nicolaus Copernicus University, Collegium Medicum, Dept. of Health PromotionVerified email at cm.umk.pl
